Riskpilot← Back to searchSign inGet full accessAqua Reviva AB
ABIn liquidationOrg 5590599089Manufacture of basic pharmaceutical products · NACE 2110Est. 20160 employees
Revenue 2021
SEK 0
EBITDA margin
—
-127% vs 2020
Equity ratio
67.9%
Financial strength
Net profit 2021
SEK -1,2M
-8229% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -226K | -127% |
| Net profit | SEK -1,2M | -8229% |
| Total assets | SEK 16,9M | +6% |
| Equity | SEK 11,5M | +14% |
| Employees | 0 | — |
Legal name
Aqua Reviva AB
Org number
5590599089
Legal form
Aktiebolag
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
21 april 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva marknadsföring och distribution av produkter inom vatten, bioteknologi, mikrobiologi, vattenrening, vattenförsörjning, avloppsrening, avfallshantering och sanering. Bolaget ska även bedriva installering av dessa produkter och finna och knyta till sig lämpliga samarbetspartners samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 50 | 0 | 2 828 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −13 | −381 | −3 115 | 834 | −226 |
| Depreciation & amort. | −0 | −0 | −0 | −848 | −940 |
| EBIT | −13 | −381 | −3 115 | −14 | −1 166 |
| Net financials | — | — | — | — | — |
| Profit before tax | −13 | −381 | −3 115 | −14 | −1 166 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 | −381 | −3 115 | −14 | −1 166 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 4 947 | 11 872 | 14 151 | 15 986 | 16 927 |
| Equity | 4 927 | 11 846 | 8 731 | 10 067 | 11 490 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 20 | 26 | 5 420 | 5 919 | 5 437 |
| Total debt | 20 | 26 | 5 420 | 5 919 | 5 437 |
EBITDA margin
-22600000.0%
This company
15.8%
Market median
-143038075% vs market
20172021
Equity ratio
67.9%
This company
38.2%
Market median
+78% vs market
20172021
Return on equity
-10.1%
This company
18.4%
Market median
-155% vs market
20172021
Net profit margin
-116600000.0%
This company
8.1%
Market median
-1439506273% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MA Liquidator | Liquidator | 2020 |
AF | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aqua Reviva AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Alexander Kristofer Hertler | Liquidator | 0 companies |
| Anders Filip Lundberg | Audit | 0 companies |
| H E Makramalla | Deputy Board Member | 0 companies |
| Ali Mohamad Ismail | Board of Directors | 0 companies |